Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 322 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Recruiting

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

NCT03562169

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Aberdeen Royal Infirmary Aberdeen, United Kingdom

Monklands Hospital Airdrie, United Kingdom

University Hospital Ayr Ayr, United Kingdom

Barnsley Hospital Barnsley, United Kingdom

View all 91 locations

View Trial Details

Recruiting

Institut Paoli Calmettes Multiple Myeloma Database

NCT02869555

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France

View Trial Details

Enrolling by Invitation

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

NCT03689595

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Enrolling by Invitation

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

NCT02473757

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by Invitation

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

NCT07499128

Conditions: Antibodies Bispecific, Blood Protein Disorders, Body Temperature, +36 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by Invitation

AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities

NCT07410403

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Enrolling by Invitation

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

NCT03628612

Conditions: ALL, Adult and Pediatric, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: University of Miami Miami, Florida, United States

Washington University in St. Louis St Louis, Missouri, United States

St David's South Austin Medical Center Austin, Texas, United States

Queen Elizabeth University Hospital Glasgow, United Kingdom

View Trial Details

Enrolling by Invitation

ASH Research Collaborative Data Hub

NCT05775224

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +20 more
Locations: ASH Research Collaborative Washington D.C., District of Columbia, United States

View Trial Details

Enrolling by Invitation

A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)

NCT03815279

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Landspitali University Hospital Reykjavik, Iceland

View Trial Details

Not Yet Recruiting

Iberdomide (CC-220) Priming to Improve T Cell Fitness Prior to Leukapheresis for Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Relapsed/Refractory Multiple Myeloma (RRMM)

NCT07727668

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions